T. Rowe Price Investment Management
KRTX

T. Rowe Price Investment Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

T. Rowe Price Investment Management’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
2023
Q4 		$858M Sell
2023
Q3 		$464M Buy
2023
Q2 		$538M Sell
2023
Q1 		$451M Buy
2022
Q4 		$236M Buy
2022
Q3 		$219M Buy